Risk Identification of Long-term Complications
1 other identifier
observational
500
1 country
1
Brief Summary
The investigators retrospectively analyze the clinical characteristics of severe COVID-19 in our hospital, and then establish a prediction model for long-term complications in patients with severe COVID-19, and strengthen follow-up to improve the prognosis of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 8, 2023
CompletedFirst Posted
Study publicly available on registry
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedMay 8, 2024
May 1, 2024
1.7 years
October 8, 2023
May 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Lung function
Pulmonary function indicators improved gradually
1 year
Imaging of the lung
The residual lesions in the lung were gradually absorbed
1 year
Study Arms (1)
Follow-up cohort of patients with severe COVID-19
The scores of various scales, pulmonary function and imaging changes of patients with severe COVID-19 were collected at 3 months, 6 months and 12 months after rehabilitation and discharge.
Interventions
According to the pulmonary rehabilitation guidelines, patients with severe COVID-19 were given regular rehabilitation treatment, including breathing exercises and physical rehabilitation exercises.
Eligibility Criteria
Patients diagnosed with severe COVID-19 in our hospital from December 8, 2022 to January 31, 2023 were enrolled
You may qualify if:
- The patient met the diagnostic criteria for severe COVID-19
You may not qualify if:
- Pregnant women Patients who died of COVID-19 Patients younger than 18 years of age without pulmonary CT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Follow-up of patients with severe COVID-19
Wuhan, 430000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2023
First Posted
February 1, 2024
Study Start
February 1, 2023
Primary Completion
September 30, 2024
Study Completion
November 1, 2025
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
The project confidentiality agreement was observed, but the IPD could be made public after the study was completed.